Journal of Research in Pharmacy Practice

Side effects reported by European consumers for medications for erectile dysfunction

Authors

. Lise Aagaard 1
. Ebba Holme Hansen 2

1 1 Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark Danish Pharmacovigilance Research Project (DANPREP), Copenhagen, Denmark

2 Section for Clinical and Social Pharmacy, Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark Danish Pharmacovigilance Research Project (DANPREP), Copenhagen, Denmark

Abstract
Objective: To characterise consumer adverse drug reaction (ADR) reports for 
phosphodiesterase type 5 (PDE5) inhibitors.
Methods: We included ADR reports submitted by adults to the European ADR 
database  (EudraVigialnce) from 2007 to 2011. ADRs were classified according to type,
seriousness and age and sex of consumers. The unit of analysis was one ADR.
Findings:Totally,328ADRs were reported for sildenafil and vardenafil,and only 5% of these
were serious.The largest number of reported ADRs was found for sildenafil, i.e., “lack of
efficacy” and/or “drug efficacy decreased” (n = 134) and “headache” (n = 21).
Conclusion: ADRs reported by consumers for PDE5 inhibitors were relatively low, and
only few ADRs were serious.

Keywords

Adverse drug reactions
consumers
erectile dysfunction
EudraVigilance
  pharmacovigilance
1. Lim PH, Moorthy P, Benton KG. The clinical safety of viagra. 
Ann N Y Acad Sci 2002;962:378‑88.
2. Young SE, Mainous AG 3rd, Diaz VA, Everett CJ. Practice 
patterns in sildenafil prescribing. Fam Med 2006;38:110‑5.
3. Jones MJ. Internet‑based prescription of sildenafil: 
A 2104‑patient series. J Med Internet Res 2001;3:E2.
4. Palit V, Eardley I. An update on new oral PDE5 inhibitors 
for the treatment of erectile dysfunction. Nat Rev Urol 
2010;7:603‑9.
5. van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. 
Experiences with adverse drug reaction reporting by patients: 
An 11‑country survey. Drug Saf 2012;35:45‑60.
6. Aagaard L, Nielsen LH, Hansen EH. Consumer reporting of 
adverse drug reactions: Aretrospective analysis of the Danish 
adverse drug reaction database from 2004 to 2006. Drug Saf 
2009;32:1067‑74.
7. European Medicines Agency. EudraVigilance. Available from: 
http://www.eudravigilance.ema.europa.eu/human/index.
asp. [Last accessed 2013 Apr 15].
8. Eudra Lex. Pharmacovigilance: Medicinal products for human 
use and veterinary products. Vol. 9. Available from: http://
www.ec.europa.eu/enterprise/pharmaceuticals/eudralex/
homev9.htm. [Last accessed 2013 Apr 15].
Journal of Research in Pharmacy Practice
Volume 2, Issue 2
Spring 2013
Pages 93-95

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us